Challenges in lung cancer therapy during the COVID-19 pandemic.

Calabrò, L.; Peters, S.; Soria, J.C.; Di Giacomo, A.M.; Barlesi, F.; Covre, A.; Altomonte, M.; Vegni, V.; Gridelli, C.; Reck, M.; Rizvi, N.; Maio, M.

doi:10.1016/S2213-2600(20)30170-3

Challenges in lung cancer therapy during the COVID-19 pandemic.

Détails

Télécharger: 32278368_BIB_C8A0BEA4C21E.pdf (665.56 [Ko])
Etat: Public
Version: Final published version
Licence: Non spécifiée

ID Serval

serval:BIB_C8A0BEA4C21E

Type

Article: article d'un périodique ou d'un magazine.

Collection

Publications

Institution

UNIL/CHUV

Titre

Challenges in lung cancer therapy during the COVID-19 pandemic.

Périodique

The Lancet. Respiratory medicine

Auteur⸱e⸱s

Calabrò L., Peters S., Soria J.C., Di Giacomo A.M., Barlesi F., Covre A., Altomonte M., Vegni V., Gridelli C., Reck M., Rizvi N., Maio M.

ISSN

2213-2619 (Electronic)

ISSN-L

2213-2600

Statut éditorial

Publié

Date de publication

06/2020

Peer-reviewed

Oui

Volume

8

Numéro

6

Pages

542-544

Langue

anglais

Notes

Publication types: Journal Article
Publication Status: ppublish

Mots-clé

Antineoplastic Agents/adverse effects, Betacoronavirus, Coronavirus Infections/complications, Coronavirus Infections/virology, Drug-Related Side Effects and Adverse Reactions/virology, Humans, Lung Neoplasms/drug therapy, Lung Neoplasms/virology, Pandemics, Pneumonia, Viral/complications, Pneumonia, Viral/virology

URN

urn:nbn:ch:serval-BIB_C8A0BEA4C21E5

OAI-PMH

oai:serval.unil.ch:BIB_C8A0BEA4C21E

DOI

10.1016/S2213-2600(20)30170-3

Pubmed

32278368

Web of science

000540618400019

Open Access

Oui